Connecting Global Healthcare, Building a New Ecosystem for Oncology Care | International Expert Delegation Visits Guangzhou Royal Lee Cancer Hospital
医疗无国界，合作向未来。7 月 17 日，由印尼外科医师 Dr AVRIANA PETY WARDANI、印尼多家医疗机构代表，黎巴嫩专家 Dr TAREK GHANNAM、美国专家 Mr AGUNG HENDRYANTO 等 20 余位海外医疗专家组成的国际医疗访问团，在印尼侨胞联合总会总主席钟家燕带队下莅临广州皇家丽肿瘤医院，围绕我院涉外医疗服务体系、国际化运营模式、前沿肿瘤诊疗技术开展全方位深度调研考察。此次跨国参访，既是全球医疗行业对我院深耕跨境肿瘤医疗多年成果的专业检阅，更印证皇家丽国际化专科建设实力持续收获全球同道广泛认可。
Healthcare knows no borders, and cooperation builds the future. On July 17, an international medical delegation of over 20 leading overseas experts, including Indonesian surgeon Dr AVRIANA PETY WARDANI, representatives from multiple Indonesian medical institutions, Lebanese expert Dr TAREK GHANNAM, and American expert MR AGUNG HENDRYANTO, visited Guangzhou Royal Lee Cancer Hospital under the leadership of Ms. Zhong Jiayan, President of the Indonesian Overseas Chinese Association. The delegation conducted an in‑depth and comprehensive investigation into our hospital’s international medical service system, global operational models, and cutting‑edge oncology technologies. This multinational visit not only served as a professional assessment by the global healthcare community of our years of achievements in cross‑border oncology care, but also reaffirmed that Royal Lee’s international specialty strength continues to gain widespread recognition from peers worldwide.
广州皇家丽肿瘤医院首席执行官杨锦植、总顾问姜文奇、副院长兼国际医疗负责人马兰英代表全院，对远道而来的国际专家代表团致以热忱欢迎，并全程陪同实地走访调研。
On behalf of the entire hospital, our CEO YEO KIM SECK, Chief Advisor Jiang Wenqi, and Vice President and Head of International Medical Services Ma Lanying extended a warm welcome to the visiting international expert delegation and accompanied them throughout the on‑site inspection and discussions.
访问团先后深入国际医疗中心、肿瘤精准诊疗中心、前沿高端诊疗设备专区等核心诊疗板块，沉浸式观摩我院标准化全流程诊疗规范、精细化人文服务管理体系、国际一流硬件设备配置，以及高效成熟的国际化临床运营闭环。从多语种一站式患者接待、精准微创肿瘤治疗技术，到跨境就医全链条配套服务，代表团全方位感受我院兼顾专业精度与人文温度的国际化办院特色，对医院在肿瘤专科领域深厚的技术积淀、前瞻性产业布局留下深刻印象。
The delegation visited our International Medical Center, Precision Oncology Center, and state‑of‑the‑art diagnostic and therapeutic equipment zones, immersing themselves in our standardized full‑process clinical protocols, refined humanistic service management, world‑class hardware infrastructure, and efficient, mature international clinical operation loop. From multilingual one‑stop patient reception and precision minimally invasive oncology techniques to the full chain of cross‑border medical support services, the delegation experienced our unique approach that balances professional excellence with humanistic warmth. They were deeply impressed by our profound technical expertise and forward‑looking strategic layout in the oncology field.
Dr AVRIANA PETY WARDANI
Dr TAREK GHANNAM
Mr AGUNG HENDRYANTO
作为粤港澳大湾区内通过 JCI 国际认证的三级肿瘤专科医院，皇家丽依托中新广州知识城国家级双边合作平台优势，搭建起辐射全球的跨境肿瘤医疗服务网络。在临床技术层面，医院深耕钇 90 微球、微创消融、基因治疗、抗肿瘤创新药物临床应用等国际前沿赛道，构建完善的疑难肿瘤个体化精准诊疗方案；在涉外服务层面，组建多语种专业服务团队，打造覆盖签证协调、专属接送、跨境 MDT 远程会诊、国际商业保险直付的一站式跨境就医服务体系。迄今为止，医院已为全球 30 多个国家和地区的外籍肿瘤患者提供高品质、有温度的国际化诊疗服务。
As a JCI‑accredited tertiary cancer hospital in the Guangdong‑Hong Kong‑Macao Greater Bay Area, Royal Lee leverages the national‑level bilateral cooperation platform of the China-Singapore Guangzhou Knowledge City to build a cross‑border oncology service network that reaches across the globe. Clinically, the hospital has deep expertise in Y‑90 microsphere therapy, minimally invasive ablation, gene therapy, and innovative anti‑cancer drug applications, developing comprehensive personalized precision treatment plans for complex tumors. On the service front, we have established a multilingual professional team and offer a one‑stop cross‑border medical service system covering visa coordination, dedicated transfers, international MDT teleconsultations, and direct billing with global commercial insurance. To date, we have delivered high‑quality, compassionate international care to cancer patients from over 30 countries and regions.
首席执行官杨锦植CEO YEO KIM SECK
印尼侨胞联合总会总主席钟家燕
Zhong Jiayan, President of the Indonesian Overseas Chinese Association
实地走访结束后，双方开展专项交流座谈会。国际调研团对我院雄厚的肿瘤专科诊疗实力、完善成熟的国际化服务配套给予高度评价，一致认定皇家丽整体建设标准、临床诊疗水平、跨境服务体系已接轨国际一流医疗机构水准。
After the site visits, both sides held a dedicated exchange symposium. The international delegation spoke highly of our strong oncology diagnostic and therapeutic capabilities and our comprehensive, mature international service infrastructure, unanimously affirming that Royal Lee’s overall standards, clinical quality, and cross‑border service systems are on par with leading international medical institutions.
总顾问姜文奇Chief Advisor Jiang Wenqi
副院长马兰英Vice President Ma Lanying
座谈会上，中外专家围绕肿瘤学术科研、中外医师互访研修、跨境多学科联合会诊、前沿抗癌技术联合落地等核心议题充分交换意见，达成多层次、常态化深度合作共识，计划携手打通跨国诊疗协作通道，为印尼、黎巴嫩、美国等多国肿瘤患者同步对接全球优质肿瘤医疗资源。
During the symposium, experts from China and abroad exchanged views on key topics including oncology research, physician exchange and training programs, cross‑border multi‑disciplinary team consultations, and collaborative implementation of advanced anti‑cancer technologies. They reached a multi‑level, long‑term consensus on deep cooperation, planning to jointly establish channels for transnational clinical collaboration, thereby connecting cancer patients in Indonesia, Lebanon, the United States, and other countries with premier global oncology resources.
交流尾声，在首席执行官杨锦植、印尼侨胞联合总会总主席钟家燕以及各国专家的见证下，副院长马兰英代表广州皇家丽肿瘤医院，分别与黎巴嫩专家 Dr TAREK GHANNAM、美国专家 Mr AGUNG HENDRYANTO 正式签署国际医疗合作协议，标志我院全球医疗合作版图再度扩容，跨国肿瘤诊疗协作迈入实质落地阶段。
At the conclusion of the exchange, in the presence of CEO Mr. YEO KIM SECK, Ms. Zhong Jiayan, President of the Indonesian Overseas Chinese Association, and experts from various countries, Vice President Ma Lanying, on behalf of Guangzhou Royal Lee Cancer Hospital, formally signed international medical cooperation agreements with Lebanese expert Dr TAREK GHANNAM and American expert Mr AGUNG HENDRYANTO respectively. This marks another expansion of our global medical cooperation network and signals that transnational oncology collaboration has entered a concrete implementation phase.
cooperation
深耕国际医疗赛道，搭建全球协作桥梁。此次多国专家联合到访与战略合作签约，是皇家丽国际化发展进程的重要里程碑。未来，我院将持续发挥粤港澳大湾区跨境肿瘤医疗标杆优势，以开放姿态联动全球医疗资源，以专业力量助力全球肿瘤诊疗事业协同发展，让先进肿瘤诊疗技术惠及世界各地患者。
With a deep commitment to international healthcare and building bridges for global collaboration, this joint visit and strategic cooperation signing represent a significant milestone in Royal Lee’s international development journey. Moving forward, our hospital will continue to leverage its benchmark position in cross‑border oncology care within the Greater Bay Area, connect global medical resources with an open mind, and contribute our professional expertise to the coordinated advancement of global cancer care—ensuring that advanced oncology technologies benefit patients around the world.